Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
520
-
Total 13F shares, excl. options
-
38.1M
-
Shares change
-
+725K
-
Total reported value, excl. options
-
$10.8B
-
Value change
-
+$194M
-
Put/Call ratio
-
0.22
-
Number of buys
-
251
-
Number of sells
-
-231
-
Price
-
$284.00
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q3 2022
581 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q3 2022.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 520 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38.1M shares
of 152M outstanding shares and own 25.04% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (4.49M shares), BlackRock Inc. (4.33M shares), STATE STREET CORP (1.58M shares), Select Equity Group, L.P. (1.48M shares), BAMCO INC /NY/ (1.43M shares), Neuberger Berman Group LLC (1.04M shares), GEODE CAPITAL MANAGEMENT, LLC (887K shares), WELLINGTON MANAGEMENT GROUP LLP (851K shares), BROWN CAPITAL MANAGEMENT LLC (823K shares), and Winslow Capital Management, LLC (691K shares).
This table shows the top 520 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.